中国荨麻疹诊疗指南（2022版）.docxVIP

【摘要】? ??荨麻疹是一种以风团和瘙痒为主要表现的常见皮肤病，部分病例存在病情迁延反复、临床疗效不佳等特点。本指南以2018版中国荨麻疹诊疗指南为基础，结合近年来国内外荨麻疹的最新研究进展，经中华医学会皮肤性病学分会荨麻疹研究中心数十位专家共同讨论后制定而成，适用于中国成人及儿童荨麻疹患者。除对荨麻疹的定义、发病机制等内容进行补充和更新外，还采用问答形式对荨麻疹分类、诊断及治疗等临床实践中重点关注的内容进行细致说明，以期为荨麻疹的诊疗提供更为全面、科学和权威的参考依据。 【关键词】? ??荨麻疹；诊断；治疗；指南基金项目：上海市级医院皮肤科临床能力促进与提升专科联盟（SHDDOI：10.35541/cjdGuideline for diagnosis and treatment of urticaria in China （2022） Centre for Urticaria Research, Chinese Society of Dermatology Corresponding authors: Xu Jinhua, Email: xjhhsyy@163.com; Hao Fei, Email: haofei62@126.com 【Abstract】????Urticaria is a common skin disease characterized by wheals and pruritus, and some refractory cases showed prolonged duration and poor response to treatment. This guideline is a refinement of the previous version of the guideline for diagnosis and treatment of urticaria in China （2018）, and is developed by dozens of experts from Centre for Urticaria Research, Chinese Society of Dermatology after joint discussions on the basis of recent clinical and investigational advances in urticaria in China and other countries. This guideline is suitable for both Chinese adults and children with urticaria. In addition to supplementing and updating the definition and pathogenesis of urticaria, the guideline also provides detailed explanations on key concerns in clinical practicethe, such as the classification, diagnosis and treatment of urticaria, in the form of questions and answers. The guideline may provide a more comprehensive, scientific and authoritative reference for diagnosis and management of urticaria.?【Key words】? ? Urticaria; Diagnosis; Therapy; GuidelineFund program: Clinical Research Plan of SHDC （SHDDOI: 10.35541/cjd 荨麻疹是一种以风团和瘙痒为主要表现的常见免疫相关性皮肤病。由于部分病例存在病情迁延反复、临床疗效不佳等特点，如何对荨麻疹开展科学、合理、安全的诊治始终备受关注。近年来，世界多个国家和机构分别制定颁布了各自的荨麻疹诊疗指南或共识，我国也在2014年和2018年发布过《中国荨麻疹诊疗指南》[1-2]。但随着最新研究进展及治疗药物的出现，以及指南制定理念和方法的更新，我国原有的荨麻疹诊疗指南需要进一步完善，以更好地指导临床实践。鉴于此，中华医学会皮肤性病学分会荨麻疹研究中心拟对现有指南的内容和形式分别进行补充和优化。本指南在2018版中国荨麻疹诊疗指南的基础上，通